Agilent Technologies Inc (A) - Total Liabilities
Based on the latest financial reports, Agilent Technologies Inc (A) has total liabilities worth $5.99 Billion USD as of October 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore A long-term investments to assets to see how much of total assets are deployed in long-term investments.
Agilent Technologies Inc - Total Liabilities Trend (1998–2025)
This chart illustrates how Agilent Technologies Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see A asset base.
Agilent Technologies Inc Competitors by Total Liabilities
The table below lists competitors of Agilent Technologies Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Humana Inc
NYSE:HUM
|
USA | $37.92 Billion |
|
Shanghai Pudong Development Bank Co Ltd
SHG:600000
|
China | CN¥9.56 Trillion |
|
Banco Bradesco DRC
BA:BBD
|
Argentina | AR$2.03 Trillion |
|
STMicroelectronics N.V
F:SGMR
|
Germany | €6.96 Billion |
|
Coca-Cola European Partners PLC
NASDAQ:CCEP
|
USA | $23.28 Billion |
|
RIO Tinto Ltd
AU:RIO
|
Australia | AU$61.12 Billion |
|
Samsung Biologics Co Ltd
KO:207940
|
Korea | ₩4.29 Trillion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €7.76 Trillion |
Liability Composition Analysis (1998–2025)
This chart breaks down Agilent Technologies Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See A equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.96 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.89 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.47 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Agilent Technologies Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Agilent Technologies Inc (1998–2025)
The table below shows the annual total liabilities of Agilent Technologies Inc from 1998 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-10-31 | $5.99 Billion | +0.64% |
| 2024-10-31 | $5.95 Billion | +20.94% |
| 2023-10-31 | $4.92 Billion | -5.91% |
| 2022-10-31 | $5.23 Billion | -1.67% |
| 2021-10-31 | $5.32 Billion | +11.82% |
| 2020-10-31 | $4.75 Billion | +1.06% |
| 2019-10-31 | $4.70 Billion | +18.49% |
| 2018-10-31 | $3.97 Billion | +10.55% |
| 2017-10-31 | $3.59 Billion | +0.50% |
| 2016-10-31 | $3.57 Billion | +7.69% |
| 2015-10-31 | $3.32 Billion | -39.38% |
| 2014-10-31 | $5.47 Billion | +1.41% |
| 2013-10-31 | $5.40 Billion | +0.86% |
| 2012-10-31 | $5.35 Billion | +12.87% |
| 2011-10-31 | $4.74 Billion | -26.61% |
| 2010-10-31 | $6.46 Billion | +26.52% |
| 2009-10-31 | $5.11 Billion | +4.67% |
| 2008-10-31 | $4.88 Billion | +12.92% |
| 2007-10-31 | $4.32 Billion | +16.44% |
| 2006-10-31 | $3.71 Billion | +38.95% |
| 2005-10-31 | $2.67 Billion | -23.43% |
| 2004-10-31 | $3.49 Billion | +0.40% |
| 2003-10-31 | $3.47 Billion | -2.88% |
| 2002-10-31 | $3.58 Billion | +53.67% |
| 2001-10-31 | $2.33 Billion | -24.08% |
| 2000-10-31 | $3.06 Billion | +48.64% |
| 1999-10-31 | $2.06 Billion | +4.94% |
| 1998-10-31 | $1.97 Billion | -- |
About Agilent Technologies Inc
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrome… Read more